Literature DB >> 23245972

Psychological stress and melanoma: are we meeting our patients' psychological needs?

Nadine Angele Kasparian1.   

Abstract

Approximately 30% of all patients diagnosed with melanoma report levels of psychological distress indicative of the need for clinical intervention. Despite this, the psychological and emotional needs of patients frequently go undetected and unmet. This contribution aims to provide clinicians and researchers with a succinct update on our understanding of the psychosocial challenges faced by individuals with melanoma. There is now strong evidence that psychological interventions can improve psychosocial outcomes for patients with melanoma, including reductions in general mood disturbance, depression, and anxiety. Further prospective cohort studies are required for a better understanding of the impact of psychological stress on melanoma survival and recurrence, as well as the potential psycho-neuro-immunological mechanisms involved.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23245972     DOI: 10.1016/j.clindermatol.2011.11.005

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  15 in total

1.  A pilot randomised controlled trial of an online mindfulness-based program for people diagnosed with melanoma.

Authors:  Lahiru Russell; Anna Ugalde; Liliana Orellana; Donna Milne; Meinir Krishnasamy; Richard Chambers; David W Austin; Patricia M Livingston
Journal:  Support Care Cancer       Date:  2018-11-30       Impact factor: 3.603

Review 2.  Surviving cutaneous melanoma: a clinical review of follow-up practices, surveillance, and management of recurrence.

Authors:  Amy A Mrazek; Celia Chao
Journal:  Surg Clin North Am       Date:  2014-08-05       Impact factor: 2.741

3.  Depression, anxiety and quality of life in long-term survivors of malignant melanoma: a register-based cohort study.

Authors:  Manfred E Beutel; Sabine Fischbeck; Harald Binder; Maria Blettner; Elmar Brähler; Katharina Emrich; Peter Friedrich-Mai; Barbara H Imruck; Veronika Weyer; Sylke R Zeissig
Journal:  PLoS One       Date:  2015-01-23       Impact factor: 3.240

4.  Assessment of Anxiety and Depression Status in Turkish Cutaneous Melanoma Patients

Authors:  Faruk Tas; Senem Karabulut; Hulya Guveli; Sidika Kurul; Kayhan Erturk; Murat Guveli; Hasibe Kinik
Journal:  Asian Pac J Cancer Prev       Date:  2017-02-01

5.  Feasibility of an online mindfulness-based program for patients with melanoma: study protocol for a randomised controlled trial.

Authors:  Lahiru Russell; Anna Ugalde; Donna Milne; Meinir Krishnasamy; Eric O Seung Chul; David W Austin; Richard Chambers; Liliana Orellana; Patricia M Livingston
Journal:  Trials       Date:  2018-04-13       Impact factor: 2.279

6.  Willingness to pay for a cure of low-risk melanoma patients in Germany.

Authors:  Matthias Augustin; Christine Blome; Andrea Forschner; Ralf Gutzmer; Axel Hauschild; Lucie Heinzerling; Elisabeth Livingstone; Carmen Loquai; Dirk Schadendorf; Jochen Utikal; Tobias Wagner; Sophia Wilden; Katharina C Kähler
Journal:  PLoS One       Date:  2018-05-24       Impact factor: 3.240

7.  Prevalence and risk factors for multimorbidity in older US patients with late-stage melanoma.

Authors:  Pragya Rai; Chan Shen; Joanna Kolodney; Kimberly M Kelly; Virginia G Scott; Usha Sambamoorthi
Journal:  J Geriatr Oncol       Date:  2020-09-25       Impact factor: 3.599

8.  The Associations of Psychological Stress with Depressive and Anxiety Symptoms among Chinese Bladder and Renal Cancer Patients: The Mediating Role of Resilience.

Authors:  Mengyao Li; Lie Wang
Journal:  PLoS One       Date:  2016-04-29       Impact factor: 3.240

9.  Psychoeducational intervention for people at high risk of developing another melanoma: a pilot randomised controlled trial.

Authors:  Mbathio Dieng; N A Kasparian; Shab Mireskandari; Phyllis Butow; Daniel Costa; Rachael Morton; Graham Mann; Scott Menzies; Anne Cust
Journal:  BMJ Open       Date:  2017-10-10       Impact factor: 2.692

10.  Psychosocial consequences of skin cancer screening.

Authors:  Patricia Markham Risica; Natalie H Matthews; Laura Dionne; Jennifer Mello; Laura K Ferris; Melissa Saul; Alan C Geller; Francis Solano; John M Kirkwood; Martin A Weinstock
Journal:  Prev Med Rep       Date:  2018-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.